期刊文献+

某院736例胃肠肝胆外科患者术后预防性使用抗凝药物合理性分析 被引量:1

Rationality of Prophylactic Use of Anticoagulants in 736 Postoperative Patients in the Gastrointestinal and Hepatobiliary Surgery Departments of a Hospital
下载PDF
导出
摘要 目的提高胃肠肝胆外科患者术后预防性使用抗凝药物的合理性。方法通过临床药学系统抽取福建省立医院肝胆外科、胃肠外科2021年接受手术治疗的住院患者的病历资料,筛选其中预防性使用抗凝药物的病历资料,分析其用药合理性,并采用Caprini风险评估模型对患者的静脉血栓栓塞症(VTE)风险因素进行分析。结果共纳入736例患者,其中胃肠外科257例(34.92%)、肝胆外科479例(65.08%)。达肝素钠使用频率最高(58.15%),其次为低分子量肝素钙(23.51%)、依诺肝素钠(21.06%)、那屈肝素钙(18.07%),其余药物使用频率均低于2%;用药疗程最短1 d,最长55 d。Caprini模型评估的高危及以上患者710例(96.47%),排名前5的危险因素分别为年龄(92.93%)、恶性肿瘤(58.70%)、严重肺部疾病(26.90%)、肥胖(19.97%)和静脉曲张(5.30%)。26例(3.53%)患者无适应证用药,18例(2.45%)患者用药疗程过长。结论该院胃肠外科、肝胆外科患者术后最常使用的预防性抗凝药物为低分子肝素类药物,用药情况基本合理,导致患者VTE风险增加的主要因素有年龄、恶性肿瘤、严重肺部疾病、肥胖和静脉曲张。 Objective To improve the rationality of prophylactic use of anticoagulants in postoperative patients in the gastrointestinal and hepatobiliary surgery departments.Methods The medical records of all inpatients who underwent surgery in hepatobiliary and gastrointestinal surgery departments in 2021 were collected by the Clinical Pharmacy Information Management System(CPIMS),the data of patients who received prophylactic use of anticoagulants were screened,and the rationality of the patients'medication was analyzed.The Caprini risk assessment model was used to analyze the risk factors of venous thromboembolism(VTE)in patients.Results A total of 736 patients were included,including 257 cases(34.92%)in the gastrointestinal surgery department and 479 cases(65.08%)in the hepatobiliary surgery department.Dalteparin sodium was the most frequently used(58.15%),followed by low-molecular-weight heparin calcium(23.51%),enoxaparin sodium(21.06%),and nadroparin calcium(18.07%),with the rest of the drugs used less than 2%.The medication duration was in the range of 1-55 d.A total of 710 patients(96.47%)were assessed to be high-risk patients by the Caprini model,and the top five risk factors were age(92.93%),malignant tumor(58.70%),severe lung disease(26.90%),obesity(19.97%),and varicose veins(5.30%).A total of 26 patients(3.53%)had no indication for prophylactic medication,while 18 patients(2.45%)had a prolonged course of medication.Conclusion Low-molecular-weight heparin is the most commonly used prophylactic anticoagulants for postoperative patients in the gastrointestinal and hepatobiliary surgery departments of the hospital.The medication situation is generally reasonable,and the main factors that increase the risk of VTE in patients include elder age,malignant tumors,severe lung diseases,obesity,and varicose veins.
作者 李姮 吴臻 黄旭慧 阳丽梅 LI Heng;WU Zhen;HUANG Xuhui;YANG Limei(Lianyungang Food and Drug Control Center,Lianyungang,Jiangsu,China 222000;Ningde Municipal Hospital of Ningde Normal University,Ningde,Fujian,China 352100;Fujian Provincial Hospital South Branch·Fujian Provincial Hospital Jinshan Branch,Fuzhou,Fujian,China 350000;Provincial Clinical Medical College of Fujian Medical University·Fujian Provincial Hospital,Fuzhou,Fujian,China 350000)
出处 《中国药业》 CAS 2023年第13期118-122,共5页 China Pharmaceuticals
关键词 胃肠外科 肝胆外科 静脉血栓栓塞症 Caprini风险评估模型 危险因素 gastrointestinal surgery hepatobiliary surgery venous thromboembolism Caprini risk assessment model risk factors
  • 相关文献

参考文献10

二级参考文献85

  • 1柳婧,高翔,陈烨,梅俏,朱良如,韩英,田丰,张虎,张晓岚,缪应雷,于晓峰,施华秀,王承党,刘玉兰,王晓艳,李学锋,钱家鸣,胡品津,曹倩.中国炎症性肠病患者深静脉血栓情况调查:一项全国多中心回顾性研究[J].中华炎性肠病杂志(中英文),2017,1(1):24-28. 被引量:25
  • 2郭辉光,周逢强,高峰,丁宝忠,徐宏.腹部手术后下肢深静脉血栓与肺栓塞临床分析[J].中国普通外科杂志,2006,15(5):392-393. 被引量:16
  • 3吴庆华.盆腔和腹部手术后抗凝药物的应用[J].中华外科杂志,2006,44(19):1297-1299. 被引量:8
  • 4预防骨科大手术深静脉血栓形成指南(草案)[J].中华骨科杂志,2007,27(10):790-792. 被引量:111
  • 5Kearon C,Akl EA,Comerota AJ. Antithrombotic therapy for VTE disease:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].{H}CHEST,2012,(2 Suppl):e419S-e494S.
  • 6Bates SM,Jaeschke R,Stevens SM. Diagnosis of DVT:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].{H}CHEST,2012,(2 Suppl):e351S-e418S.
  • 7Falck-Ytter Y,Francis CW,Johanson NA. Prevention of VTE in orthopedic surgery patients:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].{H}CHEST,2012,(2 Suppl):e278S-e325S.
  • 8Gould MK,Garcia DA,Wren SM. Prevention of VTE in nonorthopedic surgical patients:Antithrombotic Therapy and Preventionof Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].{H}CHEST,2012,(2 Suppl):e227S-e277S.
  • 9GeertsWH, BergqvistD, PineoGF,et al.Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J].Chest,2008,133(6 Suppl):381S-453S.
  • 10HillJ, TreasureT. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance[J]. BMJ, 2007,334(7602):1053-1054.

共引文献508

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部